Concepedia

Marion Haberkamp

MH

5

Publications

166

Citations

5

H-Index

2019

Active since

Affiliations

European Medicines Agency(Current)

Medicines Evaluation Board

Federal Institute for Drugs and Medical Devices

Medical University of Warsaw

Assistance Publique – Hôpitaux de Paris

Marion Haberkamp is an author at European Medicines Agency specializing in social sciences, psychiatry, and medicine.

ORCID

Top concepts

Publications per year

2019–2023

5

Publications

5

European regulators’ views on a wearable-derived performance measurement of ambulation for Duchenne muscular dystrophy regulatory trials

Marion Haberkamp, Jane Moseley, Dimitrios Athanasiou et al. · Neuromuscular Disorders · 2019 · 64 citations · Full text

Association of plasma YKL-40 with brain amyloid-β levels, memory performance, and sex in subjective memory complainers

Andrea Vergallo, Simone Lista, Pablo Lemercier et al. · Neurobiology of Aging · 2020 · 44 citations · Full text

, , +11

Blood-based systems biology biomarkers for next-generation clinical trials in Alzheimer’s disease

Harald Hampel, Andrea Vergallo, Mohammad Afshar et al. · Dialogues in Clinical Neuroscience · 2019 · 24 citations · Full text

The therapeutic potential of psychedelics: the European regulatory perspective

Florence Butlen‐Ducuing, Drummond E-Wen McCulloch, Marion Haberkamp et al. · The Lancet · 2023 · 24 citations

, , +11

The new European Medicines Agency guideline on antidepressants: a guide for researchers and drug developers

Florence Butlen‐Ducuing, Marion Haberkamp, Georgios Aislaitner et al. · European Psychiatry · 2023 · 10 citations · Full text

Rows per page

1–5 of 5